Published in J Psychopharmacol on January 01, 2005
Treatment adherence therapy in people with psychotic disorders: randomised controlled trial. Br J Psychiatry (2010) 1.81
[Reaction on 'The aftermath of the reduction in inpatient care and treatment II: cross-sectional study relating to the health, the need for care, the quality of life, social functioning and the integration in society of chronic mental patients in Amsterdam']. Tijdschr Psychiatr (2013) 1.08
Cardiovascular risk factors in outpatients with bipolar disorder. Pharmacopsychiatry (2004) 0.92
Bipolar mania and plasma amino acids: increased levels of glycine. Eur Neuropsychopharmacol (2005) 0.86
Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.83
Missense polymorphisms in three oxidative-stress enzymes (GSTP1, SOD2, and GPX1) and dyskinesias in Russian psychiatric inpatients from Siberia. Hum Psychopharmacol (2010) 0.83
Evaluating interventions to improve somatic health in severe mental illness: a systematic review. Acta Psychiatr Scand (2013) 0.82
NMDA receptor genotypes associated with the vulnerability to develop dyskinesia. Transl Psychiatry (2012) 0.81
A cross-sectional study of prescribing patterns in chronic psychiatric patients living in sheltered housing facilities. Int J Clin Pharmacol Ther (2008) 0.79
Nitric oxide and neopterin in bipolar affective disorder. Neuropsychobiology (2006) 0.78
[Suicidal ideations and suicide attempts after starting on aripiprazole, a new antipsychotic drug]. Ned Tijdschr Geneeskd (2006) 0.78
Practical recommendations for improvement of the physical health care of patients with severe mental illness. Acta Psychiatr Scand (2014) 0.77
[Chemotherapy during clozapine treatment. Increased risk of agranulocytosis?]. Tijdschr Psychiatr (2008) 0.77
Aripiprazole in chronic schizophrenia: experiences in daily practice. Acta Psychiatr Scand (2006) 0.75
[The practice guideline: 'Treatment of tobacco dependence']. Ned Tijdschr Geneeskd (2005) 0.75
[The restless legs syndrome can be treated with dopamine agonists]. Ned Tijdschr Geneeskd (2006) 0.75
Influencing CYP enzymes to boost psychiatric treatment: a review on clinical evidence. Pharmacopsychiatry (2012) 0.75
Skin disorders in chronic psychiatric illness. J Eur Acad Dermatol Venereol (2010) 0.75
[Fear of falling in a fall clinic for geriatric patients: a pilot study]. Tijdschr Gerontol Geriatr (2005) 0.75
Substantial skin disorders in psychiatric illness coincide with diabetes and addiction. J Eur Acad Dermatol Venereol (2011) 0.75
[Schizophrenia and antipsychotics associated with the metabolic syndrome. An overview]. Tijdschr Psychiatr (2008) 0.75
[Hidden diseases: tuberculosis in a woman with a severe mental illness]. Tijdschr Psychiatr (2014) 0.75
[Psychotropic drugs dispensed on the island of Bonaire]. Tijdschr Psychiatr (2012) 0.75